Neurocrine Biosciences to Partipate at the 2024 Wells Fargo Healthcare Conference on September 5 in Boston
Chief Business Development and Strategy Officer Kyle Gano and Chief Finanical Officer Matt Abernethy will present at the 2024 Wells Fargo Healthcare Conference in Boston at 8:45 a.m. Eastern Time on Thursday, September 5, 2024.
OPEN WEBCAST
Neurocrine Biosciences to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York
Chief Executive Officer Kevin Gorman, Chief Business Development and Strategy Officer Kyle Gano, and Chief Financial Officer Matt Abernethy will present at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York at 3:20 p.m. Eastern Time on Wednesday, September 4, 2024. Webcast link below.
OPEN WEBCAST
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1117568 in Adults with Schizophrenia
Neurocrine Biosciences will hold a live conference call and webcast today at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). Participants can access the live conference call by dialing 800-579-2543 (U.S.) or 785-424-1789 (International) using the conference ID: NBIX. The live webcast and accompanying slides can be accessed by clicking “Open Webcast” below. The slides can be accessed now by clicking the “Presentation Link Here”.
OPEN WEBCAST
Neurocrine Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Canaccord Genuity 44th Annual Growth Conference in Boston at 3:30 p.m. Eastern Time on Wednesday, August 14, 2024. Kyle Gano, Chief Business Development and Strategy Officer, and Todd Tushla, Vice President of Investor Relations, will present at the conference.
